Clinical consultations and investigations before and after discontinuation of endocrine therapy in women with primary breast cancer

• Hauptverfasser: Derrick Lopez (Verfasst von), Anna Kemp-Casey (Verfasst von), Christobel Saunders (Verfasst von), Elizabeth Roughead (Verfasst von), Frances Boyle (Verfasst von), Max Bulsara (Verfasst von), David Preen (Verfasst von)
• Format: Buch
• Veröffentlicht: Sax Institute, 2017-07-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Objective: Although clinical trials recommend that women with hormone-dependent primary breast cancer remain on endocrine therapy for at least 5 years, up to 60% discontinue treatment early. We determined whether these women had consulted with clinicians or had investigations for cancer recurrence o...